Clinical Trials in Baltimore

Showing 11661-11680 of 20,142 trials

Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation

NCT03072589

This study will evaluate the maximum safe dose and duration of regadenoson (Lexiscan) that can be given to people who are having a lung transplant. Regadenoson will be given as a continuous IV infusion. All participants in the study will receive a regadenoson infusion beginning in the operating room during the lung transplant procedure. Participants will be assigned a certain dose of regadenoson to be given over a 12 or 24 hour period.

Lung Transplant

Christine Lau, MD21 participantsStarted Nov 2017

Baltimore, Maryland, United States • Charlottesville, Virginia, United States

COMPLETED< 1 mile

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

NCT03112694

The purpose of this study is to understand how people with neuroendocrine tumors respond to treatment with lanreotide after having received treatment with octreotide.

Neuroendocrine Tumors

Ipsen93 participantsStarted Apr 2017

Tampa, Florida, United States • Wichita, Kansas, United States • New Orleans, Louisiana, United States +5 more locations

COMPLETED< 1 mile

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

NCT01602614

This is a clinical sampling study, and no study drugs will be administered under this protocol. Premature infants who receive intravenous ganciclovir as part of clinical care will be eligible for participation in this study. Intravenous ganciclovir will not be provided under this protocol.

Cytomegalovirus Infections

University of Alabama at Birmingham18 participantsStarted Apr 2013

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Washington D.C., District of Columbia, United States +12 more locations

Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Find Trials by Condition in Baltimore

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Per Oral Endoscopic Myotomy (POEM) for Esophagogastric Junction Outflow Obstruction (EGOO)

Immunotherapy Study for Surgically Resected Pancreatic Cancer

A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea

Study of Dupilumab (REGN668/SAR231893) Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Internet-Based and Self-Reports in Assessing Diet and Physical Activity Within AARP

Imaging Study for FdCyd and THU Cancer Treatment

Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients

Pharmacokinetics of Anti-epileptic Drugs in Obese Children

Vaccine Study for Surgically Resected Pancreatic Cancer

Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

My Life, My Healthcare

VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Participants With Late-Onset Pompe Disease

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma